Related medicinesNalfurafineDifelikefalin
Where it comes from
- Made in
- The same neurons as dynorphin A, cut from the end of prodynorphin
- Sent out by
- With dynorphin A
- Acts on
- Kappa receptors
- Developing heart cells in culture
What it does
In medicine
- No medicine copies it. The approved kappa agonists, nalfurafine and difelikefalin, act at the receptor it shares with dynorphin A, so nothing distinguishes it at the bedside
- It is not measured in practice. Because it begins with the same seven residues as dynorphin A, it was separated from it only when the peptide was purified in its own right in 1982 1
Beyond the body’s own use
- Nothing containing it is in trials, and no analogue of it has been given to a person
- The one claim made for it beyond opioid signalling is cardiac: it was reported to drive embryonic stem cells towards heart muscle through a nuclear opioid route, a line of work that stayed with one laboratory 3
- What distinguishes it from dynorphin A is largely what it does not do. In lipid vesicles dynorphin A and big dynorphin leak the membrane and dynorphin B does not, which is how the non-opioid toxicity of this family was pinned on the longer peptides 2
Sources
- Kilpatrick et al., Rimorphin, a naturally occurring Leu-enkephalin-containing peptide, PNAS 1982
- Hugonin et al., Membrane leakage induced by dynorphins, FEBS Letters 2006
- Ventura et al., Protein kinase C signalling transduces endorphin-primed cardiogenesis in embryonic stem cells, Circulation Research 2003
This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.